New Insulins, Biosimilars, and Insulin Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

New Insulins, Biosimilars, and Insulin Therapy

Published:2016-02 Issue:S1 Volume:18 Page:S-43-S-55
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Danne Thomas¹,Heinemann Lutz²,Bolinder Jan³

Affiliation:

1. Diabetes-Zentrum für Kinder and Jugendliche, Kinder- und Jugendkrankenhaus “AUF DER BULT,” Hannover, Germany.

2. Science & Co., Düsseldorf, Germany.

3. Department of Medicine, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, Sweden.

Publisher

Mary Ann Liebert Inc

Subject

Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.liebertpub.com/doi/pdf/10.1089/dia.2016.2505

Reference16 articles.

1. Investigational new insulin glargine 300 U/ml has the same metabolism as insulin glargine 100 U/ml

2. Insulin glargine metabolite 21A-Gly-human insulin (M1) is the principal component circulating in the plasma of young children with type 1 diabetes: results from the PRESCHOOL study

3. Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia

4. Patient‐level meta‐analysis of the EDITION 1, 2 and 3 studies: glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus glargine 100 U/ml in people with type 2 diabetes

5. Insulin degludec's ultra-long pharmacokinetic properties observed in adults are retained in children and adolescents with type 1 diabetes

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microneedles in diagnostic, treatment and theranostics: An advancement in minimally-invasive delivery system;Biomedical Microdevices;2021-12-08

2. Si l'ère des insulines semi-synthétiques et biosynthétiques nous était contée;Médecine des Maladies Métaboliques;2021-06

3. Human insulin — is there still a place for it in everyday practice?;Clinical Diabetology;2018-05-21

4. Préparations insuliniques au cours de la dernière décennie.;Médecine des Maladies Métaboliques;2018-03

5. What Is New in Diabetes Technology?;The Journal for Nurse Practitioners;2017-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3